Treating depression after initial treatment failure: Directly comparing switch and augmenting strategies in STAR*D

Journal of Clinical Psychopharmacology

Volumn 32, Issue 1, 2012, Pages 114-119

  Gaynes, Bradley N ^a   Dusetzina, Stacie B ^b   Ellis, Alan R ^c   Hansen, Richard A ^d,e   Farley, Joel F ^e   Miller, William C ^f   Stürmer, Til ^f  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d AUBURN UNIVERSITY   (United States)

^e University of North Carolina   (United States)

^f IL   (United States)

Author keywords

major depressive disorder; outcome; propensity score; treatment resistance

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; SERTRALINE; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL DECISION MAKING; CLINICAL PROTOCOL; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROPENSITY SCORE; QUALITY OF LIFE; RATING SCALE; REMISSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; BUSPIRONE; CITALOPRAM; CYCLOHEXANOLS; DEPRESSIVE DISORDER, MAJOR; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG SUBSTITUTION; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; PERSONALITY INVENTORY; PSYCHOMETRICS; QUALITY OF LIFE; SERTRALINE; UNITED STATES; YOUNG ADULT;

EID: 84855343817     PISSN: 02710749     EISSN: 1533712X     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31823f705d     Document Type: Article

References (27)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet. 1997;349(9064):1498- 1504. (Pubitemid 27216360)
2. Gartlehner G, Gaynes BN, Hansen RA, et al. Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians. Ann Intern Med. 2008;149(10):734-750.
3. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40. (Pubitemid 43050100)
4. Fava M, Rush AJ, Trivedi MH, et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am. 2003;26(2):457-494, x. (Pubitemid 36583573)
5. Rush A, Fava M, Wisniewski SR, et al. Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design. Control Clin Trials. 2004;25(1):119-142. (Pubitemid 38230109)
6. Lavori P, Rush A, Wisniewski S, et al. Strengthening clinical effectiveness trials: equipoise-stratified randomization. Biol Psychiatry. 2001;50(10):792-801. (Pubitemid 33086767)
7. Rush AJ. STAR*D: what have we learned? Am J Psychiatry. 2007;164(2):201-204.
8. Wisniewski SR, Fava M, Trivedi MH, et al. Acceptability of second-step treatments to depressed outpatients: a STAR*D report. Am J Psychiatry. 2007;164(5):753-760. (Pubitemid 46808530)
9. Nelson JC, Pikalov A, Berman RM. Augmentation treatment in major depressive disorder: focus on aripiprazole. Neuropsychiatr Dis Treat. 2008;4(5):937-948.
10. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 1968;16(5):622-626.
11. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res. 1992;41(3):237-248.
12. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
13. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278-296.
14. Rush AJ, Bernstein IH, Trivedi MH, et al. An evaluation of the Quick Inventory of Depressive Symptomatology and the Hamilton Rating Scale for Depression: a sequenced treatment alternatives to relieve depression (STAR*D) trial report. Biol Psychiatry. 2006;59(6): 493-501. (Pubitemid 43320536)
15. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry. 2003;54(5):573-583. (Pubitemid 37289444)
16. Gandek B, Ware JE, Aaronson NK, et al. Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol. 1998;51(11):1171-1178. (Pubitemid 28527173)
17. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29(2):321-326. (Pubitemid 23311543)
18. Wisniewski SRP, Rush AJ, Bryan CP, et al. Comparison of quality of life measures in a depressed population. J Nerv Ment Dis. 2007;195(3):219-225. (Pubitemid 46673542)
19. Allison P. Missing Data. Sage University Papers Series on Quantitative Applications in the Social Sciences. Thousand Oaks, CA: Sage; 2002.
20. Graham JW. Missing data analysis: making it work in the real world. Annu Rev Psychol. 2009;60(6):1-628.
21. Robbins AS, Chao SY, Fonseca VP. What's the relative risk? A method to directly estimate risk ratios in cohort studies of common outcomes. Ann Epidemiol. 2002;12(7):452-454.
22. Deakin J, O'Loughlin C. STAR*D: a summary and UK perspective. J Psychopharmacol. 2009;23(6):605-612.
23. Hansen RA, Moore CG, Dusetzina SB, et al. Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose. Med Decis Making. 2009;29(1):91-103.
24. Nelson JC, Papakostas GI. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials. Am J Psychiatry. 2009;166(9):980-991.
25. Papakostas GI, Thase ME, Fava M, et al. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents. Biol Psychiatry. 2007;62(11):1217-1227. (Pubitemid 350060895)
26. Ruhé HG, Huyser J, Swinkels JA, et al. Switching antidepressants after a first selective serotonin reuptake inhibitor in major depressive disorder: a systematic review. J Clin Psychiatry. 2006;67(12): 1836-1855. (Pubitemid 46055194)
27. Nelson JC. Augmentation and combination strategies in resistant depression. J Clin Psychiatry. 2009;70(6):e20.